Literature DB >> 3383021

Cerebral metastases from malignant melanoma.

I M Mendez1, R F Del Maestro.   

Abstract

Six hundred and fifty-two patients with histologically proven primary malignant melanoma have been followed by the London Regional Cancer Centre from 1960 to 1985. Neurological signs and symptoms secondary to metastases to the brain developed in fifty-five patients (8.4%). The median age was 49 years; 71% were male and 29% female. Multiple lesions were found in 61% and a single metastasis in 39%. The most common site for the primary lesion was the trunk in males (44%) and the lower limb in females (37%). Six month survival for patients with a single metastasis was 58% if surgical excision was possible and 25% of these patients survived greater than two years. In patients with multiple metastases that received radiotherapy, survival times of greater than six months were found in 12% of the patients. Patients with a single metastasis appear to benefit by being managed by surgical removal of the lesion.

Entities:  

Mesh:

Year:  1988        PMID: 3383021     DOI: 10.1017/s0317167100027463

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  4 in total

Review 1.  Multiple intracranial melanoma metastases: case report and review of the literature.

Authors:  Aslan Guzel; Jaroslaw Maciaczyk; Hildegard Dohmen-Scheufler; Senem Senturk; Benedikt Volk; Christoph B Ostertag; Guido Nikkhah
Journal:  J Neurooncol       Date:  2009-02-01       Impact factor: 4.130

2.  Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.

Authors:  Jeffrey J Raizer; Wen-Jen Hwu; Katherine S Panageas; Andrew Wilton; Drew E Baldwin; Elizabeth Bailey; Caroline von Althann; Lynne A Lamb; Gladys Alvarado; Mark H Bilsky; Philip H Gutin
Journal:  Neuro Oncol       Date:  2008-02-20       Impact factor: 12.300

3.  Intrathecal IgM response in disseminated cerebrospinal metastasis from malignant melanoma.

Authors:  M Weller; A Stevens; N Sommer; H Wiethölter
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

4.  Prognostic evaluation of intracranial metastasis in malignant melanoma.

Authors:  S Saha; M Meyer; E T Krementz; S Hoda; R D Carter; J Muchmore; C Sutherland
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.